Ant Group Open-Sources Ling-3.0-flash-Fin for Real-World Financial Workflows
9.9.2026 10:36:00 CEST | Business Wire | Press Release
Ant Group today announced the open-sourcing of Ling-3.0-flash-Fin at the 2026 Inclusion·Conference on the Bund. Grounded in actual business needs as an open model for real-world financial workflows, this release continues Ant Group's exploration of bringing AI into practical scenarios, focusing on delivering utility and high efficiency for complex tasks.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260908565055/en/
Solving Real-World Challenges Through Efficiency
Financial work depends on trustworthy sources, consistent definitions, accurate calculations and auditable outputs. AI in this sector must go beyond simple question-and-answer interactions to navigate dynamic information, complex accounting standards, and stringent compliance requirements. Ling-3.0-flash-Fin was co-developed with leading financial institutions and industry experts to embed professional expertise directly into task definition, data systems, and evaluation frameworks, guided by the principles of being professional, efficient, and open.
Built on a highly efficient Mixture-of-Experts (MoE) architecture, Ling-3.0-flash-Fin features 124 billion total parameters but activates only 5.1 billion per token. This design delivers the comprehensive knowledge capacity of a large model while maintaining the low inference costs and high deployment efficiency of a compact model.
This architectural efficiency translates into strong practical performance, with the model showing competitive results across various benchmarks including FinFIRST, FinSearchComp Verified, FinCRAFT, FinanceAgent v1.1/v2, APEX-Agents, SpreadsheetBench v1/v2, and τ³-Banking.
Core Capabilities for Professional Workflows
Ling-3.0-flash-Fin focuses on four core capabilities tailored for investment research and financial analysis:
- Information Retrieval: Prioritizes authoritative, official sources to ensure data consistency and end-to-end traceability.
- Research Reasoning: Synthesizes multi-source, heterogeneous data to construct clear, verifiable logical evidence chains.
- Valuation Modeling: Understands complex Excel financial linkages, supporting automated updates while keeping files fully editable.
- Report Generation: Integrates facts, calculations, and visual charts to produce highly readable, professional research outputs.
Now, Ling-3.0-flash-Fin is available on OpenRouter and Vercel and its open weights can be accessed through Hugging Face and ModelScope. Users can deploy it privately, connect it to search, Python, databases and spreadsheets, and adapt it to their own financial workflows.
Alongside the model, Ant Group is also open-sourcing FinFIRST, an expert-built benchmark for financial search agents. Developed with professional support from the investment banking team at China International Capital Corporation Limited (CICC), FinFIRST V1 includes 123 expert-authored tasks, 701 atomic criteria, and 12,300 rubric points. By evaluating the full research process rather than relying solely on final-answer matching, FinFIRST ensures strict data consistency and end-to-end traceability in complex financial scenarios.
A Broader Ecosystem for Diverse Needs
Recognizing that different industries and scenarios require specialized solutions, the Ling 3.0 series offer a rich portfolio of models beyond Ling-3.0-flash-Fin.
- Ling-3.0-flash: A hybrid-reasoning MoE model built for production-scale agents, featuring 124B total parameters with 5.1B active per token. It achieves performance comparable to flagship 1T models on most benchmarks while reducing compute requirements significantly.
- Ling-3.0-tiny: A native hybrid reasoning model with 7.9B total parameters and 1.3B active per token. Designed for resource-sensitive deployment, it runs entirely locally without cloud dependency, ideal for personal knowledge management and offline tasks.
- Ling-3.0-flash-VL: A vision-language model built on Ling-3.0-flash, adding image and video inputs with a 1M token context. It is designed for visual perception, STEM reasoning, document intelligence, multimodal agent tasks, and medical report interpretation.
- Ling-3.0-flash-Santé: An MoE model enhanced for healthcare and life sciences, achieving top-tier performance among flash-size models on key medical benchmarks like MedXpertQA-Text and DiagnosisArena-MCQ, delivering flagship-level performance for clinical reasoning and evidence-based retrieval.
About Ant Group
Ant Group is a global digital technology provider and the operator of Alipay, a leading internet services platform in China, connecting over one billion users to more than 10,000 types of consumer services from partners. Through innovative products and solutions powered by AI, blockchain and other technologies, Ant Group supports partners across industries to thrive through digital transformation in an ecosystem for inclusive and sustainable development. For more information, visit www.antgroup.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20260908565055/en/
Contacts
Media Inquiries
Vick Li Wei
Ant Group
vick.lw@antgroup.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Final MINT Study Results Strengthen Real-World Evidence for Mogamulizumab (Poteligeo ® ) in Patients With Mycosis Fungoides and Sézary Syndrome12.10.2026 08:00:00 CEST | Press Release
Kyowa Kirin International plc, a wholly owned subsidiary of Kyowa Kirin Co., Ltd. (TSE:4151, Kyowa Kirin), today announced final results from the German MINT study evaluating mogamulizumab in patients with mycosis fungoides (MF) and Sézary Syndrome (SS). Presented at the European Organisation for Research and Treatment of Cancer Cutaneous Lymphoma Tumour Group (EORTC-CLTG) Annual Meeting 2026 in Berlin, Germany, the findings represent one of the largest real-world evaluations of mogamulizumab in Germany and add to the growing body of evidence supporting its use in routine clinical practice.1-3 Conducted as a company-sponsored, multicentric, non-interventional, combined retro-prospective real-world study across 18 centres throughout Germany, MINT brought together cutaneous T‑cell lymphoma (CTCL) specialists to evaluate treatment outcomes with mogamulizumab in a real-world setting, with time-to-next-treatment (TTNT) as the study’s primary endpoint.1 The study captured a broad and heterog
Megaport Expands Global Automated Infrastructure Platform Into Portugal12.10.2026 08:00:00 CEST | Press Release
Megaport Limited (ASX: MP1) (“Megaport”), a leading global automated infrastructure platform, today announced the launch of its services in Portugal, expanding its European footprint and enabling enterprises and service providers in the region to connect instantly to the world’s leading cloud, network, and data center providers. With new on-ramps in Lisbon, customers in Portugal can now access Megaport’s automated infrastructure platform as well as more than 1,200 enabled data centers worldwide. This launch gives enterprises, MSPs, and carriers private, high-performance compute, network, and storage, as well as on-demand regional interconnection with scalable bandwidth. With Portugal’s data center market projected to reach US$3.09 billion by 2030 as well as Lisbon’s proximity to major submarine cable landings, the strengthening global connectivity hub is a natural next step for Megaport. “Portugal’s digital economy is rapidly growing, and infrastructure is at the heart of that transfor
Filippo Fagnani from Quanta System Receives the EAU Award for Significant Contribution to Endourology at ICE 202610.10.2026 18:09:00 CEST | Press Release
Filippo Fagnani, Marketing & Scientific Director of Quanta System’s Surgical Division, has been honoured with the Award for Significant Contribution to Endourology at ICE26, the International Conference on Endourology organised by the EAU Endourology Section. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261010101303/en/ Filippo Fagnani receiving the prize with Olivier Traxer and Professor Bhaskar Somani. The recognition celebrates more than two decades of professional commitment to laser technology and a career built around a clear ambition: to translate the needs of urologists into increasingly precise, flexible and useful technologies, with the ultimate goal of supporting patient safety and better surgical outcomes. “I have always believed that technology should make the surgeon’s work more precise, more flexible and, most importantly, safer for the patient. My goal has never been to develop technology for its own sake,
Emdoor Information Marks 18 Years of Rugged Computing Excellence with Vertically Integrated Capabilities10.10.2026 12:30:00 CEST | Press Release
As industrial automation, smart manufacturing, and field operations increasingly depend on mission-critical mobile computing, global demand for reliable rugged tablets, rugged laptops, and rugged handhelds continues to accelerate. Emdoor Information, a publicly listed company on China’s A-share main board since 2023 and an 18-year veteran in rugged computing, has established itself as a rugged computing solutions provider for industrial customers worldwide. Founded in 2008, the company delivers sustained growth, world-class manufacturing, resilient supply chains, full-stack R&D, and comprehensive lifecycle services. Its rugged computing products and industrial customers now span North America, Latin America, Europe, and Asia-Pacific, serving sectors such as public utilities, intelligent manufacturing, warehouse management, transportation, energy industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261010564561/en/ Rugged
Vertex to Present New Data on ALYFTREK ® at the North American Cystic Fibrosis Conference9.10.2026 19:15:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced new interim data from the ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor) 2 to 5 years old open-label extension study, highlighting recovery of exocrine pancreatic function in some children in that age group, allowing those children to discontinue pancreatic enzyme replacement therapy (PERT). Pancreatic exocrine insufficiency in children with cystic fibrosis (CF) was previously believed to be irreversible. These data were presented at the North American Cystic Fibrosis Conference (NACFC). “The data presented at NACFC underscore the safety and efficacy of our CF medicines in the real world and in clinical trials in younger age groups. The data from the Phase 3 open-label study in 2 to 5 year olds evaluating exocrine pancreatic function represent a profound shift in how we understand the benefits of treating cystic fibrosis in its earliest stages,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Devel
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom